TABLE 2.
Results of antiviral treatment on the presence of autoimmune markers
| Autoimmune marker | No. of patients positive for indicated autoimmune marker who were:
|
|||||
|---|---|---|---|---|---|---|
| Nontreated (n = 10)
|
Nonresponsive (n = 6)
|
Responsive (n = 9)
|
||||
| Prea | Postb | Prea | Postb | Prea | Postb | |
| Cryoglobulin | 3 | 3 | 3 | 2 | 3 | 0 |
| RF | 4 | 4 | 2 | 2 | 4 | 0 |
| Autoantibodyc | 6 | 7 | 3 | 3 | 5 | 1 |
a
“Pre” indicates the results of baseline evaluations made for all patients whether or not they received treatment.
b
For nontreated patients, “Post” indicates the results for assessments made 12 months after the baseline evaluation. For treated patients, “Post” refers to the results of assessments made after treatment.
c
Autoantibodies may include anti-nuclear, anti-smooth muscle, and/or anti-cardiolipin antibodies.